You claim to have been taking advantage of every "buying opportunity" since at least the mid 5's. One has to wonder just how many shares you hold?
Unless you can show more than a 7 month old website I have to believe Vdex does NOT exist.
10,000,000 patients x$2,000 per year............ Did you say 10,000,000 patients? I thought there are only 200 patients a week buying Afrezza?
Well it hasn't been that long since they announced opening, just a little over a half of a year. There is a poster on this board who claims to have opened 15 neuropathy clinics this year and Vdex can't get one open in over a half of a year and people still are holding on to the hope that it's going to happen.....WOW!
If you have been involved in class-action suits as I have on several occasion, you would know that the only people who get their money, no matter who prevails, are the attorneys. You will get crumbs.
You almost got me. Your post had me thinking they were actually company helping diabetics. I got an email from them in response to an inquiry I made, it turns out they are nothing more than a website. Nothing has changed in a half year.
It's almost time for him to dust off that one about the Indian doctor claiming inhaled insulin is going to replace injectables within the year.
When referring to Victoza as garbage I was making the point that even if it was it doesn't help Afrezza. Time has proven that.
Why 1-10 RS? So that they can bonus themselves for a job well done. Isn't that what they've been doing all along. Do you really think Matt cares about anyone but himself? They will dilute and "they" will put your money in their pocket, EOS.
Doesn't matter who or if he "finger's" anybody, it isn't going to get you your money back and for that you have my sympathy.
Never gonna happen. 1 for 10 RS, which real still leaves too many shares to allow for the secondary that will follow. No way they park this gravy train.
That's gotta make you wonder just how useless afrezza is when a toxic Victoza outsells Afrezza by a bunch. You're a back of the envelope kinda guy($2,350/share) why don't you put your pencil to the Victozza/Afrezza sales comparison and tell us what you come up with?
Two realities.........Victoza's is garbage and Afrezza can't get traction. Somehow you think if Victoza, which out sells Afrezza by a gazillion is bad that makes Afrezza a money maker. Guess what it ain't working out that way. You really are a DA. Go drink some more strawberry wine you #$%$.